nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—PTGS2—thyroid cancer	0.781	1	CbGaD
Drospirenone—Infarction—Sorafenib—thyroid cancer	0.0113	0.111	CcSEcCtD
Drospirenone—PTGS2—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.00641	0.0552	CbGpPWpGaD
Drospirenone—Embolism venous—Sorafenib—thyroid cancer	0.00621	0.0613	CcSEcCtD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00546	0.047	CbGpPWpGaD
Drospirenone—NR3C2—Preimplantation Embryo—NKX2-1—thyroid cancer	0.00516	0.0445	CbGpPWpGaD
Drospirenone—Embolism—Sorafenib—thyroid cancer	0.00488	0.0482	CcSEcCtD
Drospirenone—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.00482	0.0415	CbGpPWpGaD
Drospirenone—NR3C2—Preimplantation Embryo—TCF7L1—thyroid cancer	0.00455	0.0391	CbGpPWpGaD
Drospirenone—AR—Coregulation of Androgen receptor activity—NCOA4—thyroid cancer	0.0045	0.0387	CbGpPWpGaD
Drospirenone—PGR—Nuclear Receptors—THRB—thyroid cancer	0.00421	0.0362	CbGpPWpGaD
Drospirenone—Venous thromboembolism—Epirubicin—thyroid cancer	0.00394	0.0389	CcSEcCtD
Drospirenone—AR—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.00381	0.0328	CbGpPWpGaD
Drospirenone—Venous thromboembolism—Doxorubicin—thyroid cancer	0.00365	0.036	CcSEcCtD
Drospirenone—PGR—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00333	0.0286	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—NCOA4—thyroid cancer	0.00332	0.0286	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptors—THRB—thyroid cancer	0.00321	0.0276	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.00319	0.0275	CbGpPWpGaD
Drospirenone—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT19—thyroid cancer	0.00287	0.0247	CbGpPWpGaD
Drospirenone—PTGS2—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.00262	0.0226	CbGpPWpGaD
Drospirenone—Depression—Vandetanib—thyroid cancer	0.00259	0.0256	CcSEcCtD
Drospirenone—AR—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00253	0.0218	CbGpPWpGaD
Drospirenone—Haemoglobin—Vandetanib—thyroid cancer	0.00235	0.0231	CcSEcCtD
Drospirenone—Haemorrhage—Vandetanib—thyroid cancer	0.00233	0.023	CcSEcCtD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00232	0.02	CbGpPWpGaD
Drospirenone—Embolism venous—Epirubicin—thyroid cancer	0.0023	0.0227	CcSEcCtD
Drospirenone—Erythema multiforme—Vandetanib—thyroid cancer	0.00221	0.0218	CcSEcCtD
Drospirenone—Mood swings—Sorafenib—thyroid cancer	0.00216	0.0213	CcSEcCtD
Drospirenone—Embolism venous—Doxorubicin—thyroid cancer	0.00212	0.021	CcSEcCtD
Drospirenone—Angiopathy—Vandetanib—thyroid cancer	0.00212	0.0209	CcSEcCtD
Drospirenone—Breast disorder—Sorafenib—thyroid cancer	0.00206	0.0203	CcSEcCtD
Drospirenone—Mental disorder—Vandetanib—thyroid cancer	0.00204	0.0202	CcSEcCtD
Drospirenone—Embolism—Epirubicin—thyroid cancer	0.00181	0.0178	CcSEcCtD
Drospirenone—PGR—Nuclear Receptors—RXRA—thyroid cancer	0.00179	0.0154	CbGpPWpGaD
Drospirenone—PTGS2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00174	0.015	CbGpPWpGaD
Drospirenone—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00173	0.0171	CcSEcCtD
Drospirenone—Myocardial infarction—Sorafenib—thyroid cancer	0.00172	0.017	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00172	0.0169	CcSEcCtD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.0017	0.0147	CbGpPWpGaD
Drospirenone—Embolism—Doxorubicin—thyroid cancer	0.00167	0.0165	CcSEcCtD
Drospirenone—Thrombosis—Epirubicin—thyroid cancer	0.00164	0.0162	CcSEcCtD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L1—thyroid cancer	0.00163	0.014	CbGpPWpGaD
Drospirenone—Nervous system disorder—Vandetanib—thyroid cancer	0.00163	0.016	CcSEcCtD
Drospirenone—Skin disorder—Vandetanib—thyroid cancer	0.00161	0.0159	CcSEcCtD
Drospirenone—Haemoglobin—Sorafenib—thyroid cancer	0.00158	0.0156	CcSEcCtD
Drospirenone—Haemorrhage—Sorafenib—thyroid cancer	0.00157	0.0155	CcSEcCtD
Drospirenone—Thrombosis—Doxorubicin—thyroid cancer	0.00151	0.0149	CcSEcCtD
Drospirenone—PGR—Nuclear signaling by ERBB4—NRG1—thyroid cancer	0.00151	0.013	CbGpPWpGaD
Drospirenone—Erythema multiforme—Sorafenib—thyroid cancer	0.00149	0.0147	CcSEcCtD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00146	0.0126	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00143	0.0141	CcSEcCtD
Drospirenone—Angiopathy—Sorafenib—thyroid cancer	0.00143	0.0141	CcSEcCtD
Drospirenone—PGR—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00141	0.0122	CbGpPWpGaD
Drospirenone—Mental disorder—Sorafenib—thyroid cancer	0.00138	0.0136	CcSEcCtD
Drospirenone—AR—Nuclear Receptors—RXRA—thyroid cancer	0.00136	0.0117	CbGpPWpGaD
Drospirenone—Breast pain—Epirubicin—thyroid cancer	0.00133	0.0131	CcSEcCtD
Drospirenone—NR3C2—Generic Transcription Pathway—TRIM33—thyroid cancer	0.0013	0.0112	CbGpPWpGaD
Drospirenone—Breast pain—Doxorubicin—thyroid cancer	0.00123	0.0121	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00116	0.0114	CcSEcCtD
Drospirenone—PGR—Nuclear Receptors—PPARG—thyroid cancer	0.00113	0.00972	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00111	0.00959	CbGpPWpGaD
Drospirenone—Nervous system disorder—Sorafenib—thyroid cancer	0.0011	0.0108	CcSEcCtD
Drospirenone—Skin disorder—Sorafenib—thyroid cancer	0.00109	0.0107	CcSEcCtD
Drospirenone—AR—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00108	0.00927	CbGpPWpGaD
Drospirenone—AR—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.00104	0.00899	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00104	0.00892	CbGpPWpGaD
Drospirenone—Nausea—Vandetanib—thyroid cancer	0.000985	0.00972	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000966	0.00953	CcSEcCtD
Drospirenone—NR3C2—Generic Transcription Pathway—THRB—thyroid cancer	0.000943	0.00812	CbGpPWpGaD
Drospirenone—PGR—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000892	0.00768	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptors—PPARG—thyroid cancer	0.00086	0.0074	CbGpPWpGaD
Drospirenone—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000858	0.00847	CcSEcCtD
Drospirenone—AR—Notch-mediated HES/HEY network—HIF1A—thyroid cancer	0.000853	0.00735	CbGpPWpGaD
Drospirenone—Affect lability—Epirubicin—thyroid cancer	0.000828	0.00817	CcSEcCtD
Drospirenone—Migraine—Epirubicin—thyroid cancer	0.000828	0.00817	CcSEcCtD
Drospirenone—Mood swings—Epirubicin—thyroid cancer	0.000797	0.00786	CcSEcCtD
Drospirenone—PGR—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000794	0.00684	CbGpPWpGaD
Drospirenone—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000794	0.00784	CcSEcCtD
Drospirenone—Affect lability—Doxorubicin—thyroid cancer	0.000766	0.00756	CcSEcCtD
Drospirenone—Migraine—Doxorubicin—thyroid cancer	0.000766	0.00756	CcSEcCtD
Drospirenone—Breast disorder—Epirubicin—thyroid cancer	0.00076	0.0075	CcSEcCtD
Drospirenone—Mood swings—Doxorubicin—thyroid cancer	0.000737	0.00727	CcSEcCtD
Drospirenone—AR—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.000718	0.00618	CbGpPWpGaD
Drospirenone—Breast disorder—Doxorubicin—thyroid cancer	0.000703	0.00694	CcSEcCtD
Drospirenone—AR—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000688	0.00593	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00068	0.00585	CbGpPWpGaD
Drospirenone—Nausea—Sorafenib—thyroid cancer	0.000664	0.00656	CcSEcCtD
Drospirenone—PGR—Signaling by ERBB4—CDK1—thyroid cancer	0.000635	0.00547	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—TRIM33—thyroid cancer	0.000628	0.00541	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000605	0.00521	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—MEN1—thyroid cancer	0.000599	0.00516	CbGpPWpGaD
Drospirenone—Haemoglobin—Epirubicin—thyroid cancer	0.000585	0.00577	CcSEcCtD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—thyroid cancer	0.000583	0.00502	CbGpPWpGaD
Drospirenone—Haemorrhage—Epirubicin—thyroid cancer	0.000582	0.00574	CcSEcCtD
Drospirenone—PGR—Generic Transcription Pathway—THRB—thyroid cancer	0.000574	0.00495	CbGpPWpGaD
Drospirenone—Erythema multiforme—Epirubicin—thyroid cancer	0.00055	0.00543	CcSEcCtD
Drospirenone—AR—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000544	0.00469	CbGpPWpGaD
Drospirenone—Haemoglobin—Doxorubicin—thyroid cancer	0.000541	0.00534	CcSEcCtD
Drospirenone—Haemorrhage—Doxorubicin—thyroid cancer	0.000538	0.00531	CcSEcCtD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.000529	0.00455	CbGpPWpGaD
Drospirenone—Angiopathy—Epirubicin—thyroid cancer	0.000528	0.00521	CcSEcCtD
Drospirenone—PGR—Signaling by ERBB4—NRG1—thyroid cancer	0.00051	0.00439	CbGpPWpGaD
Drospirenone—Mental disorder—Epirubicin—thyroid cancer	0.00051	0.00503	CcSEcCtD
Drospirenone—Erythema multiforme—Doxorubicin—thyroid cancer	0.000509	0.00502	CcSEcCtD
Drospirenone—PTGS2—Spinal Cord Injury—LGALS3—thyroid cancer	0.000499	0.0043	CbGpPWpGaD
Drospirenone—Angiopathy—Doxorubicin—thyroid cancer	0.000488	0.00482	CcSEcCtD
Drospirenone—Mental disorder—Doxorubicin—thyroid cancer	0.000472	0.00465	CcSEcCtD
Drospirenone—NR3C2—Gene Expression—THRB—thyroid cancer	0.000454	0.00391	CbGpPWpGaD
Drospirenone—AR—Nongenotropic Androgen signaling—HRAS—thyroid cancer	0.000453	0.0039	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—THRB—thyroid cancer	0.000438	0.00377	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000428	0.00423	CcSEcCtD
Drospirenone—AR—Coregulation of Androgen receptor activity—CCND1—thyroid cancer	0.000419	0.0036	CbGpPWpGaD
Drospirenone—Nervous system disorder—Epirubicin—thyroid cancer	0.000405	0.004	CcSEcCtD
Drospirenone—Skin disorder—Epirubicin—thyroid cancer	0.000402	0.00396	CcSEcCtD
Drospirenone—NR3C2—Generic Transcription Pathway—RXRA—thyroid cancer	0.000401	0.00345	CbGpPWpGaD
Drospirenone—AR—Nongenotropic Androgen signaling—AKT1—thyroid cancer	0.0004	0.00345	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—thyroid cancer	0.000397	0.00342	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000396	0.00391	CcSEcCtD
Drospirenone—PGR—Gene Expression—TRIM33—thyroid cancer	0.000382	0.00329	CbGpPWpGaD
Drospirenone—Nervous system disorder—Doxorubicin—thyroid cancer	0.000375	0.0037	CcSEcCtD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000374	0.00322	CbGpPWpGaD
Drospirenone—Skin disorder—Doxorubicin—thyroid cancer	0.000372	0.00367	CcSEcCtD
Drospirenone—PGR—Generic Transcription Pathway—MEN1—thyroid cancer	0.000365	0.00314	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000361	0.00311	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000357	0.00352	CcSEcCtD
Drospirenone—PTGS2—Spinal Cord Injury—CDK1—thyroid cancer	0.000341	0.00293	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—thyroid cancer	0.000337	0.0029	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00033	0.00326	CcSEcCtD
Drospirenone—AR—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000327	0.00281	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—CCND1—thyroid cancer	0.000309	0.00266	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—TPR—thyroid cancer	0.000307	0.00264	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—PTEN—thyroid cancer	0.000299	0.00257	CbGpPWpGaD
Drospirenone—AR—Gene Expression—TRIM33—thyroid cancer	0.000291	0.00251	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MEN1—thyroid cancer	0.000288	0.00248	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—MEN1—thyroid cancer	0.000278	0.00239	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000278	0.00239	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—THRB—thyroid cancer	0.000277	0.00238	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CALCB—thyroid cancer	0.000262	0.00226	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.00026	0.00224	CbGpPWpGaD
Drospirenone—NR3C2—saliva-secreting gland—thyroid cancer	0.000257	0.124	CbGeAlD
Drospirenone—PGR—Signaling by ERBB4—PTEN—thyroid cancer	0.000255	0.0022	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—PPARG—thyroid cancer	0.000253	0.00218	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—MINPP1—thyroid cancer	0.00025	0.00215	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000249	0.00214	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TRIM33—thyroid cancer	0.000249	0.00214	CbGpPWpGaD
Drospirenone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000247	0.00213	CbGpPWpGaD
Drospirenone—Nausea—Epirubicin—thyroid cancer	0.000246	0.00242	CcSEcCtD
Drospirenone—PGR—Generic Transcription Pathway—RXRA—thyroid cancer	0.000244	0.0021	CbGpPWpGaD
Drospirenone—AR—Coregulation of Androgen receptor activity—AKT1—thyroid cancer	0.000233	0.002	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—NRAS—thyroid cancer	0.000228	0.00196	CbGpPWpGaD
Drospirenone—Nausea—Doxorubicin—thyroid cancer	0.000227	0.00224	CcSEcCtD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000224	0.00192	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000215	0.00185	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NDUFA13—thyroid cancer	0.000212	0.00183	CbGpPWpGaD
Drospirenone—AR—Gene Expression—THRB—thyroid cancer	0.000211	0.00181	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000203	0.00175	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CHST14—thyroid cancer	0.0002	0.00172	CbGpPWpGaD
Drospirenone—NR3C2—trachea—thyroid cancer	0.000199	0.096	CbGeAlD
Drospirenone—PGR—Signaling by ERBB4—KRAS—thyroid cancer	0.000196	0.00169	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000196	0.00168	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—RXRA—thyroid cancer	0.000193	0.00166	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.00019	0.00164	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—TPR—thyroid cancer	0.000187	0.00161	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	0.000186	0.0016	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—RXRA—thyroid cancer	0.000186	0.0016	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000186	0.0016	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000186	0.0016	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000185	0.0016	CbGpPWpGaD
Drospirenone—BCHE—Phospholipid metabolism—PTEN—thyroid cancer	0.000176	0.00151	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MEN1—thyroid cancer	0.000176	0.00151	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TRIM24—thyroid cancer	0.000175	0.0015	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—AKT1—thyroid cancer	0.000172	0.00148	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MINPP1—thyroid cancer	0.000172	0.00148	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000168	0.00145	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—HRAS—thyroid cancer	0.000167	0.00144	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TCF7L1—thyroid cancer	0.000166	0.00143	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CHST14—thyroid cancer	0.000164	0.00141	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000162	0.0014	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HPGD—thyroid cancer	0.000161	0.00139	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	0.00016	0.00138	CbGpPWpGaD
Drospirenone—NR3C2—thyroid gland—thyroid cancer	0.000157	0.076	CbGeAlD
Drospirenone—PTGS2—Disease—TRIM33—thyroid cancer	0.000156	0.00134	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—PPARG—thyroid cancer	0.000154	0.00133	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.00015	0.00129	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—AKT1—thyroid cancer	0.000147	0.00127	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NDUFA13—thyroid cancer	0.000146	0.00126	CbGpPWpGaD
Drospirenone—PGR—thyroid gland—thyroid cancer	0.000146	0.0706	CbGeAlD
Drospirenone—AR—Gene Expression—TPR—thyroid cancer	0.000142	0.00123	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—BRAF—thyroid cancer	0.000142	0.00122	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	0.000142	0.00122	CbGpPWpGaD
Drospirenone—NR3C2—head—thyroid cancer	0.000139	0.0674	CbGeAlD
Drospirenone—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	0.000138	0.00119	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CHST14—thyroid cancer	0.000137	0.00118	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MEN1—thyroid cancer	0.000134	0.00115	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000134	0.00115	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000131	0.00112	CbGpPWpGaD
Drospirenone—PGR—head—thyroid cancer	0.00013	0.0626	CbGeAlD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000124	0.00107	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PPARG—thyroid cancer	0.000122	0.00105	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TSHR—thyroid cancer	0.000121	0.00105	CbGpPWpGaD
Drospirenone—BCHE—trachea—thyroid cancer	0.00012	0.0579	CbGeAlD
Drospirenone—PGR—Signaling Pathways—PRKAR1A—thyroid cancer	0.000119	0.00103	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—RXRA—thyroid cancer	0.000117	0.00101	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PPARG—thyroid cancer	0.000117	0.00101	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	0.000117	0.00101	CbGpPWpGaD
Drospirenone—AR—thyroid gland—thyroid cancer	0.000116	0.0563	CbGeAlD
Drospirenone—PGR—Signaling Pathways—MEN1—thyroid cancer	0.000114	0.000983	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000113	0.000971	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HPGD—thyroid cancer	0.000111	0.000954	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000111	0.000953	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TCF7L1—thyroid cancer	0.000104	0.000894	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTCH1—thyroid cancer	0.000103	0.000889	CbGpPWpGaD
Drospirenone—AR—head—thyroid cancer	0.000103	0.0499	CbGeAlD
Drospirenone—NR3C2—lymph node—thyroid cancer	9.76e-05	0.0472	CbGeAlD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	9.66e-05	0.000832	CbGpPWpGaD
Drospirenone—BCHE—thyroid gland—thyroid cancer	9.46e-05	0.0458	CbGeAlD
Drospirenone—PGR—Signaling Pathways—SST—thyroid cancer	9.44e-05	0.000813	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	9.35e-05	0.000805	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	9.34e-05	0.000804	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	9.32e-05	0.000803	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TPR—thyroid cancer	9.24e-05	0.000796	CbGpPWpGaD
Drospirenone—PTGS2—trachea—thyroid cancer	9.22e-05	0.0446	CbGeAlD
Drospirenone—BCHE—Metabolism—PRKAR1A—thyroid cancer	9.09e-05	0.000783	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CALCA—thyroid cancer	9.09e-05	0.000783	CbGpPWpGaD
Drospirenone—PGR—lymph node—thyroid cancer	9.07e-05	0.0439	CbGeAlD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.99e-05	0.000774	CbGpPWpGaD
Drospirenone—AR—Gene Expression—RXRA—thyroid cancer	8.95e-05	0.000771	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—HRAS—thyroid cancer	8.52e-05	0.000734	CbGpPWpGaD
Drospirenone—BCHE—head—thyroid cancer	8.39e-05	0.0406	CbGeAlD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.24e-05	0.00071	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDK1—thyroid cancer	8.23e-05	0.000709	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TPR—thyroid cancer	7.6e-05	0.000654	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRKAR1A—thyroid cancer	7.47e-05	0.000644	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PPARG—thyroid cancer	7.42e-05	0.000639	CbGpPWpGaD
Drospirenone—AR—lymph node—thyroid cancer	7.22e-05	0.0349	CbGeAlD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	7.16e-05	0.000616	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MEN1—thyroid cancer	7.14e-05	0.000615	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SLC5A5—thyroid cancer	6.92e-05	0.000596	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NRG1—thyroid cancer	6.61e-05	0.000569	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—HRAS—thyroid cancer	6.53e-05	0.000562	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.48e-05	0.000558	CbGpPWpGaD
Drospirenone—PTGS2—head—thyroid cancer	6.47e-05	0.0313	CbGeAlD
Drospirenone—PTGS2—Metabolism—TPR—thyroid cancer	6.36e-05	0.000548	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	6.36e-05	0.000548	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PRKAR1A—thyroid cancer	6.26e-05	0.000539	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TERT—thyroid cancer	5.93e-05	0.000511	CbGpPWpGaD
Drospirenone—BCHE—lymph node—thyroid cancer	5.88e-05	0.0284	CbGeAlD
Drospirenone—BCHE—Metabolism—RXRA—thyroid cancer	5.81e-05	0.000501	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CALCA—thyroid cancer	5.69e-05	0.00049	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.67e-05	0.000489	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HIF1A—thyroid cancer	5.67e-05	0.000488	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.65e-05	0.000487	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARG—thyroid cancer	5.65e-05	0.000487	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.37e-05	0.000463	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDK1—thyroid cancer	5.15e-05	0.000443	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AKT1—thyroid cancer	4.82e-05	0.000415	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC5A5—thyroid cancer	4.76e-05	0.00041	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—BRAF—thyroid cancer	4.7e-05	0.000404	CbGpPWpGaD
Drospirenone—PTGS2—lymph node—thyroid cancer	4.53e-05	0.0219	CbGeAlD
Drospirenone—PTGS2—Disease—NRG1—thyroid cancer	4.13e-05	0.000356	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—RXRA—thyroid cancer	4e-05	0.000345	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.89e-05	0.000335	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TERT—thyroid cancer	3.71e-05	0.000319	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARG—thyroid cancer	3.67e-05	0.000316	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HIF1A—thyroid cancer	3.55e-05	0.000306	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCND1—thyroid cancer	3.43e-05	0.000295	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTEN—thyroid cancer	3.31e-05	0.000285	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NRAS—thyroid cancer	2.95e-05	0.000254	CbGpPWpGaD
Drospirenone—PTGS2—Disease—BRAF—thyroid cancer	2.94e-05	0.000253	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AKT1—thyroid cancer	2.93e-05	0.000253	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—thyroid cancer	2.89e-05	0.000249	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KRAS—thyroid cancer	2.54e-05	0.000219	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARG—thyroid cancer	2.53e-05	0.000218	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTEN—thyroid cancer	2.52e-05	0.000217	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—thyroid cancer	2.26e-05	0.000194	CbGpPWpGaD
Drospirenone—AR—Gene Expression—AKT1—thyroid cancer	2.23e-05	0.000192	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HRAS—thyroid cancer	2.16e-05	0.000186	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PTEN—thyroid cancer	2.07e-05	0.000178	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT1—thyroid cancer	1.91e-05	0.000164	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NRAS—thyroid cancer	1.85e-05	0.000159	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PTEN—thyroid cancer	1.73e-05	0.000149	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KRAS—thyroid cancer	1.59e-05	0.000137	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKT1—thyroid cancer	1.45e-05	0.000125	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HRAS—thyroid cancer	1.35e-05	0.000116	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT1—thyroid cancer	1.19e-05	0.000103	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKT1—thyroid cancer	9.99e-06	8.6e-05	CbGpPWpGaD
